Artelo Biosciences to Present at Biocom’s 10th Annual Global Life Sciences Partnering Conference Feb 24, 2020 9:00am EST
Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program Feb 03, 2020 8:30am EST
Artelo Biosciences Reports First Quarter Fiscal Year 2020 Financial Results and Provides Business Update Jan 14, 2020 8:00am EST
Artelo Biosciences Announces Appointment of Seasoned Finance and Industry Executive John W. Beck to Board of Directors Dec 09, 2019 8:30am EST
Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update Nov 25, 2019 8:00am EST
Artelo Biosciences Announces Publication of Positive Non-Clinical Fatty Acid Binding Protein 5 Inhibitor Data in Peer-Reviewed Journal Nov 18, 2019 8:30am EST
